Article Versions Notes

Dubois C, Martin F, Hassel C, Magnier F, Daumar P, Aubel C, Guerder S, Mounetou E, Penault-Lorca F, Bamdad M. Low-Dose and Long-Term Olaparib Treatment Sensitizes MDA-MB-231 and SUM1315 Triple-Negative Breast Cancers Spheroids to Fractioned Radiotherapy. Journal of Clinical Medicine. 2020; 9(1):64. https://doi.org/10.3390/jcm9010064

Dubois, Clémence, Fanny Martin, Chervin Hassel, Florian Magnier, Pierre Daumar, Corinne Aubel, Sylvie Guerder, Emmanuelle Mounetou, Frédérique Penault-Lorca, and Mahchid Bamdad. 2020. "Low-Dose and Long-Term Olaparib Treatment Sensitizes MDA-MB-231 and SUM1315 Triple-Negative Breast Cancers Spheroids to Fractioned Radiotherapy" Journal of Clinical Medicine 9, no. 1: 64. https://doi.org/10.3390/jcm9010064

Dubois, C., Martin, F., Hassel, C., Magnier, F., Daumar, P., Aubel, C., Guerder, S., Mounetou, E., Penault-Lorca, F., & Bamdad, M. (2020). Low-Dose and Long-Term Olaparib Treatment Sensitizes MDA-MB-231 and SUM1315 Triple-Negative Breast Cancers Spheroids to Fractioned Radiotherapy. Journal of Clinical Medicine, 9(1), 64. https://doi.org/10.3390/jcm9010064